Medtronic received information via literature regarding multi-center experience on percutaneous pulmonary valve implantation in small conduits.All data were collected from multiple centers between may 2008¿july 2016.The study population included 14 patients (mean age 12 years), all of whom were implanted with medtronic melody device; 3 patients had been previously implanted with contegra pulmonary valved conduit.The serial numbers were not provided.Among all patients adverse events included: mild pulmonary valve regurgitation.Based on the available information, this adverse event can be attributed to medtronic product.No additional adverse patient effects or product performance problems were reported.
|